Literature DB >> 25053350

Predictors of quality of life in patients evaluated for liver transplantation.

Maximilian Jara1, Jan Bednarsch, Maciej Malinowski, Katja Lüttgert, James Orr, Gero Puhl, Daniel Seehofer, Peter Neuhaus, Martin Stockmann.   

Abstract

INTRODUCTION: Health-related quality of life (HRQOL) is severely impaired in advanced liver disease. The purpose of this study was to evaluate the impact of actual liver function and disease-specific factors on HRQOL of patients evaluated for liver transplantation. PATIENTS AND METHODS: Disease-specific QOL was analyzed in 142 patients evaluated for liver transplantation using the German version of the Chronic Liver Disease Questionnaire (CLDQ-D). We performed quantitative liver function tests and collected clinical and demographical data of patients after their referral to our transplant department. Values were correlated with CLDQ-D scores.
RESULTS: Neither model for end-stage liver disease (MELD) nor dynamic liver function test results were related to quality of life. Serum albumin concentration was a strong but not independent factor correlated with global CLDQ-D (r = 0.269, p < 0.001). Independent predictors of global CLDQ-D were ascites and butyrylcholinesterase serum concentration (B = -0.486, p < 0.001 and B = 0.196, p = 0.002, respectively).
CONCLUSION: Actual liver function is not related to decreased quality of life, whereas ascites and hypoproteinemia represent the major factors influencing physical and social aspects of daily life in potential liver transplant candidates.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ascites; health-related quality of life; hypoproteinemia; liver transplantation; quality of life; transplant candidates

Mesh:

Year:  2014        PMID: 25053350     DOI: 10.1111/ctr.12426

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  6 in total

1.  Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.

Authors:  Maria Stepanova; Fatema Nader; Christophe Bureau; Danielle Adebayo; Laure Elkrief; Dominique Valla; Markus Peck-Radosavljevic; Anne McCune; Victor Vargas; Macarena Simon-Talero; Juan Cordoba; Paolo Angeli; Silvia Rossi; Stewart MacDonald; Jeroen Capel; Rajiv Jalan; Zobair M Younossi
Journal:  Qual Life Res       Date:  2018-02-19       Impact factor: 4.147

2.  Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Authors:  Christian Benzing; Nicco Krezdorn; Julia Förster; Andreas Hinz; Felix Krenzien; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

3.  Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document.

Authors:  Lucia Macken; Margaret Corrigan; Wendy Prentice; Fiona Finlay; Joanne McDonagh; Neil Rajoriya; Claire Salmon; Mhairi Donnelly; Catherine Evans; Bhaskar Ganai; Joan Bedlington; Shani Steer; Mark Wright; Ben Hudson; Sumita Verma
Journal:  Frontline Gastroenterol       Date:  2022-06-10

4.  Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.

Authors:  Myrte Neijenhuis; Tom J G Gevers; Thomas D Atwell; Tim J Gunneson; Amanda C Schimek; Wietske Kievit; Joost P H Drenth; Patrick S Kamath
Journal:  Am J Gastroenterol       Date:  2018-03-20       Impact factor: 10.864

5.  The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.

Authors:  Yvonne Alt; Anna Grimm; Liesa Schlegel; Annette Grambihler; Jens M Kittner; Jörg Wiltink; Peter R Galle; Marcus A Wörns; Jörn M Schattenberg
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

6.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.